Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing.


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
01 2022
Historique:
received: 28 07 2021
accepted: 07 01 2022
revised: 08 02 2022
pubmed: 28 1 2022
medline: 3 3 2022
entrez: 27 1 2022
Statut: epublish

Résumé

Chronic inflammation is often associated with the development of tissue fibrosis, but how mesenchymal cell responses dictate pathological fibrosis versus resolution and healing remains unclear. Defining stromal heterogeneity and identifying molecular circuits driving extracellular matrix deposition and remodeling stands to illuminate the relationship between inflammation, fibrosis, and healing. We performed single-cell RNA-sequencing of colon-derived stromal cells and identified distinct classes of fibroblasts with gene signatures that are differentially regulated by chronic inflammation, including IL-11-producing inflammatory fibroblasts. We further identify a transcriptional program associated with trans-differentiation of mucosa-associated fibroblasts and define a functional gene signature associated with matrix deposition and remodeling in the inflamed colon. Our analysis supports a critical role for the metalloprotease Adamdec1 at the interface between tissue remodeling and healing during colitis, demonstrating its requirement for colon epithelial integrity. These findings provide mechanistic insight into how inflammation perturbs stromal cell behaviors to drive fibroblastic responses controlling mucosal matrix remodeling and healing.

Identifiants

pubmed: 35085231
doi: 10.1371/journal.pbio.3001532
pii: PBIOLOGY-D-21-02023
pmc: PMC8824371
doi:

Substances chimiques

Interleukin-11 0
Sodium Dodecyl Sulfate 368GB5141J
ADAM Proteins EC 3.4.24.-
Adamdec1 protein, mouse EC 3.4.24.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3001532

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK043351
Pays : United States
Organisme : NIDDK NIH HHS
ID : RC2 DK114784
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007191
Pays : United States

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: R.J.X. is a cofounder of Celsius Therapeutics and Jnana Therapeutics.

Références

Cancer Immunol Res. 2018 Dec;6(12):1472-1485
pubmed: 30266714
Nature. 2018 Jul;559(7714):356-362
pubmed: 29973725
Cell Syst. 2019 Apr 24;8(4):281-291.e9
pubmed: 30954476
Curr Opin Gastroenterol. 2017 Jul;33(4):234-238
pubmed: 28562487
Front Immunol. 2018 Aug 16;9:1896
pubmed: 30177933
Arthritis Res Ther. 2010;12(2):R60
pubmed: 20359365
Sci Transl Med. 2019 Sep 25;11(511):
pubmed: 31554736
Nat Commun. 2018 Feb 23;9(1):789
pubmed: 29476097
Cell. 2015 Jan 15;160(1-2):269-84
pubmed: 25594183
J Biol Chem. 2017 Jun 16;292(24):10112-10122
pubmed: 28455445
Respir Res. 2010 Mar 18;11:31
pubmed: 20298567
Nat Immunol. 2019 Jul;20(7):928-942
pubmed: 31061532
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Curr Protoc Immunol. 2014 Feb 04;104:15.25.1-15.25.14
pubmed: 24510619
J Cell Biol. 1999 Jun 14;145(6):1189-98
pubmed: 10366592
Cell. 2017 Jan 26;168(3):362-375
pubmed: 28129537
Nat Commun. 2017 Jan 06;8:13824
pubmed: 28059064
Exp Cell Res. 1996 Nov 1;228(2):283-91
pubmed: 8912722
Cell Rep. 2021 Aug 3;36(5):109484
pubmed: 34348153
Cell Stem Cell. 2020 Mar 5;26(3):391-402.e5
pubmed: 32084389
Immunity. 2018 May 15;48(5):1014-1028.e6
pubmed: 29752062
Cell Rep. 2018 Mar 27;22(13):3625-3640
pubmed: 29590628
J Crohns Colitis. 2016 Oct;10(10):1194-204
pubmed: 26995183
Nature. 2017 Dec 7;552(7683):110-115
pubmed: 29160304
Science. 2012 Oct 5;338(6103):108-13
pubmed: 22956684
Nature. 1995 Jan 26;373(6512):347-9
pubmed: 7530333
Am J Physiol Renal Physiol. 2010 Mar;298(3):F662-71
pubmed: 20007347
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
N Engl J Med. 2015 Mar 19;372(12):1138-49
pubmed: 25785971
Nature. 2020 Jun;582(7811):259-264
pubmed: 32499639
Front Immunol. 2015 Jun 18;6:319
pubmed: 26150817
J Anat. 2003 Jan;202(1):105-12
pubmed: 12587925
Physiol Rev. 2019 Jan 1;99(1):665-706
pubmed: 30475656
Genes Dev. 2003 Jan 1;17(1):7-30
pubmed: 12514095
Toxins (Basel). 2016 Apr 23;8(4):122
pubmed: 27120619
Differentiation. 2016 Sep;92(3):116-131
pubmed: 27165847
Nat Rev Mol Cell Biol. 2014 Dec;15(12):802-12
pubmed: 25355505
Nat Rev Immunol. 2018 Dec;18(12):745-758
pubmed: 30242265
Nat Rev Mol Cell Biol. 2014 Dec;15(12):771-85
pubmed: 25370693
J Cell Sci. 2003 Jun 15;116(Pt 12):2461-70
pubmed: 12734395
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):688
pubmed: 29018274
Nat Cell Biol. 2020 Sep;22(9):1033-1041
pubmed: 32884148
Development. 2018 Aug 1;145(15):
pubmed: 30068689
J Endocrinol. 2003 Dec;179(3):405-15
pubmed: 14656210
Nat Methods. 2017 Oct;14(10):979-982
pubmed: 28825705
Genome Biol. 2019 Dec 23;20(1):296
pubmed: 31870423
Front Immunol. 2011 Sep 12;2:35
pubmed: 22566825
Virchows Arch. 2008 Jan;452(1):57-63
pubmed: 18040712
Nature. 2014 Jan 16;505(7483):327-34
pubmed: 24429631
Annu Rev Physiol. 2016;78:243-76
pubmed: 26667078
Nat Immunol. 2014 Jul;15(7):623-30
pubmed: 24813163
Mol Cell. 1998 Apr;1(5):673-83
pubmed: 9660951
Mucosal Immunol. 2015 Sep;8(5):959-68
pubmed: 26174765
PLoS One. 2014 Sep 04;9(9):e106732
pubmed: 25188209
Trends Cell Biol. 2021 Mar;31(3):152-165
pubmed: 33349527
Cell. 2018 Oct 4;175(2):372-386.e17
pubmed: 30270042
Biochim Biophys Acta. 2014 Aug;1840(8):2506-19
pubmed: 24418517
Cell Tissue Res. 2009 Jan;335(1):5-16
pubmed: 18972135
J Immunol. 2002 Jul 1;169(1):424-33
pubmed: 12077273
Nat Med. 2017 May;23(5):579-589
pubmed: 28368383
Aliment Pharmacol Ther. 2011 Sep;34(5):533-43
pubmed: 21736598
Cancer Discov. 2019 Nov;9(11):1574-1589
pubmed: 31434712
Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):19-34
pubmed: 30429586
Lab Invest. 1985 Jan;52(1):71-6
pubmed: 3880842
J Biol Chem. 2013 Jul 19;288(29):21367-21375
pubmed: 23754285
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
J Invest Dermatol. 2018 Apr;138(4):802-810
pubmed: 29080679
Open Rheumatol J. 2012;6:146-55
pubmed: 22802913
Int J Inflam. 2015;2015:970890
pubmed: 26839731
J Biol Chem. 1996 Mar 22;271(12):7095-103
pubmed: 8636144
Hypertension. 1988 Jun;11(6 Pt 2):620-6
pubmed: 2455687
Gastroenterology. 1990 Mar;98(3):694-702
pubmed: 1688816
PLoS Biol. 2020 Dec 11;18(12):e3001032
pubmed: 33306673
Nature. 2017 Nov 2;551(7678):100-104
pubmed: 29072293
Proteomics. 2017 Dec;17(23-24):
pubmed: 29027377
Gastroenterology. 2004 Jan;126(1):111-21
pubmed: 14699493
Bioinformatics. 2019 Jul 15;35(14):2495-2497
pubmed: 30520965
Nat Commun. 2021 Apr 16;12(1):2281
pubmed: 33863879
J Biochem. 2017 Jan;161(1):19-25
pubmed: 28013225
Sci Transl Med. 2014 Apr 9;6(231):231ra47
pubmed: 24718857
J Cell Biol. 1999 Feb 22;144(4):789-801
pubmed: 10037799
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Stem Cells Int. 2017;2017:7970385
pubmed: 28835755
Nat Genet. 2004 Oct;36(10):1117-21
pubmed: 15378062
Circ Res. 2009 Mar 13;104(5):576-88
pubmed: 19286613
Nat Commun. 2019 Feb 8;10(1):650
pubmed: 30737373
Immunogenetics. 2002 May;54(2):96-105
pubmed: 12037602
Inflammopharmacology. 2012 Feb;20(1):1-18
pubmed: 22205271
Front Endocrinol (Lausanne). 2018 Oct 15;9:601
pubmed: 30374330
Am J Pathol. 2009 Aug;175(2):605-15
pubmed: 19628764
Growth Horm IGF Res. 2007 Feb;17(1):33-40
pubmed: 17126585
Cell. 2019 Jul 25;178(3):714-730.e22
pubmed: 31348891
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Gastroenterology. 1968 May;54(5):835-51
pubmed: 5652518
Nature. 2021 May;593(7860):575-579
pubmed: 33981032
Nature. 2019 Feb;566(7745):496-502
pubmed: 30787437
J Crohns Colitis. 2016 Dec;10(12):1417-1427
pubmed: 27226416
Semin Immunol. 2018 Feb;35:48-58
pubmed: 29198601
Nature. 2020 Apr;580(7804):524-529
pubmed: 32322056
Cell. 2019 Sep 5;178(6):1493-1508.e20
pubmed: 31474370
Nat Immunol. 2012 Apr 01;13(5):499-510
pubmed: 22466668
Trends Cell Biol. 2018 Sep;28(9):709-722
pubmed: 29807713
AJNR Am J Neuroradiol. 2011 May;32(5):791-3
pubmed: 20966060
PLoS One. 2013 Oct 21;8(10):e77575
pubmed: 24204877
Gastroenterology. 2019 Sep;157(3):777-792.e14
pubmed: 31078624
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15418-23
pubmed: 17881565
Inflamm Bowel Dis. 2019 Apr 11;25(5):820-830
pubmed: 30445504
Exp Cell Res. 2003 Jan 15;282(2):90-100
pubmed: 12531695
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
Nature. 2013 Dec 12;504(7479):277-281
pubmed: 24336287
Nature. 2019 Jun;570(7760):246-251
pubmed: 31142839
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Cytokine Growth Factor Rev. 2013 Jun;24(3):269-83
pubmed: 23587803
Science. 2015 Apr 17;348(6232):aaa2151
pubmed: 25883361
Trends Immunol. 2015 Jan;36(1):30-9
pubmed: 25499856
Inflamm Bowel Dis. 2011 Jan;17(1):193-201
pubmed: 20848532
Am J Physiol Cell Physiol. 2005 Feb;288(2):C272-81
pubmed: 15483224
Gastroenterology. 2017 Feb;152(2):340-350.e6
pubmed: 27720839
Am J Physiol Gastrointest Liver Physiol. 2001 May;280(5):G1022-9
pubmed: 11292612
Cell Rep. 2018 Jul 24;24(4):838-850
pubmed: 30044981
J Exp Med. 1992 Nov 1;176(5):1477-82
pubmed: 1402691
Front Endocrinol (Lausanne). 2018 Apr 09;9:117
pubmed: 29686648
Nat Genet. 2017 Feb;49(2):262-268
pubmed: 28067912
Gastroenterology. 2006 Jun;130(7):2060-73
pubmed: 16762629

Auteurs

Guadalupe J Jasso (GJ)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Harvard Medical School, Boston, Massachusetts, United States of America.

Alok Jaiswal (A)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.

Mukund Varma (M)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.

Tyler Laszewski (T)

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.

Angelo Grauel (A)

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.

Abdifatah Omar (A)

Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Nilsa Silva (N)

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.

Glenn Dranoff (G)

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.

Jeffrey A Porter (JA)

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.

Keith Mansfield (K)

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.

Viviana Cremasco (V)

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America.

Aviv Regev (A)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Howard Hughes Medical Institute and David H. Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.

Ramnik J Xavier (RJ)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Harvard Medical School, Boston, Massachusetts, United States of America.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.

Daniel B Graham (DB)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Harvard Medical School, Boston, Massachusetts, United States of America.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH